Menopause Market by Treatment (Dietary Supplements, OTC Pharma Products), Product Type (Gel, Injection, Oral Dosage), Indication, Distribution Challenge - Global Forecast 2024-2030

Menopause Market by Treatment (Dietary Supplements, OTC Pharma Products), Product Type (Gel, Injection, Oral Dosage), Indication, Distribution Challenge - Global Forecast 2024-2030


The Menopause Market size was estimated at USD 17.79 billion in 2023 and expected to reach USD 18.99 billion in 2024, at a CAGR 6.85% to reach USD 28.29 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Menopause Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Menopause Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Menopause Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Apotex Inc., Astellas Pharma Inc., Bayer AG, Cipla Inc., Eli Lilly and Company, Fervent Pharmaceuticals, LLC, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Merck & Co.Inc., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc..

Market Segmentation & Coverage

This research report categorizes the Menopause Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment

Dietary Supplements

OTC Pharma Products
Hormonal products

Combination Estrogen and Other Medicines

Combination Estrogen and Progestin Medicines

Estrogen-Only Medicines

Progestin-Only Medicines
Non-hormonal products
Product Type

Gel

Injection

Oral Dosage

Patch

Pill

Powder

Skin Cream

Skin Spray (Transdermal)

Vaginal Cream

Vaginal Ring
Indication

Dry Eyes

Dry Skin

Hot Flashes

Mood Swings, Mild depression & Irritability

Night Sweats and Cold Flashes.

Osteoporosis

Trouble Sleeping

Urinary Urgency

Vaginal Dryness
Distribution Challenge

Hospital Pharmacies

Online Stores

Retail Pharmacies
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Menopause Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Menopause Market?
3. What are the technology trends and regulatory frameworks in the Menopause Market?
4. What is the market share of the leading vendors in the Menopause Market?
5. Which modes and strategic moves are suitable for entering the Menopause Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Menopause Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of vasomotor and other menopausal symptoms
5.1.1.2. Rising awareness regarding menopause health
5.1.1.3. Increasing number of new drug approvals for the treatment
5.1.2. Restraints
5.1.2.1. Side effects associated with hormonal products and the availability of generic medicines
5.1.3. Opportunities
5.1.3.1. Prevalence of herbal treatment for menopause
5.1.3.2. Increasing research supporting the advantages of dietary supplements
5.1.4. Challenges
5.1.4.1. Lack of advanced healthcare infrastructure in developing nations
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Menopause Market, by Treatment
6.1. Introduction
6.2. Dietary Supplements
6.3. OTC Pharma Products
6.4.1. Hormonal products
6.4.2.1. Combination Estrogen and Other Medicines
6.4.2.2. Combination Estrogen and Progestin Medicines
6.4.2.3. Estrogen-Only Medicines
6.4.2.4. Progestin-Only Medicines
6.4.2. Non-hormonal products
7. Menopause Market, by Product Type
7.1. Introduction
7.2. Gel
7.3. Injection
7.4. Oral Dosage
7.5. Patch
7.6. Pill
7.7. Powder
7.8. Skin Cream
7.9. Skin Spray (Transdermal)
7.10. Vaginal Cream
7.11. Vaginal Ring
8. Menopause Market, by Indication
8.1. Introduction
8.2. Dry Eyes
8.3. Dry Skin
8.4. Hot Flashes
8.5. Mood Swings, Mild depression & Irritability
8.6. Night Sweats and Cold Flashes.
8.7. Osteoporosis
8.8. Trouble Sleeping
8.9. Urinary Urgency
8.10. Vaginal Dryness
9. Menopause Market, by Distribution Challenge
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Stores
9.4. Retail Pharmacies
10. Americas Menopause Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Menopause Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Menopause Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbvie Inc.
14.1.2. Apotex Inc.
14.1.3. Astellas Pharma Inc.
14.1.4. Bayer AG
14.1.5. Cipla Inc.
14.1.6. Eli Lilly and Company
14.1.7. Fervent Pharmaceuticals, LLC
14.1.8. GlaxoSmithKline plc
14.1.9. Glenmark Pharmaceuticals Ltd.
14.1.10. Merck & Co.Inc.
14.1.11. Mithra Pharmaceuticals
14.1.12. Novartis AG
14.1.13. Pfizer Inc.
14.1.14. Teva Pharmaceutical Industries Ltd.
14.1.15. TherapeuticsMD Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. MENOPAUSE MARKET RESEARCH PROCESS
FIGURE 2. MENOPAUSE MARKET SIZE, 2023 VS 2030
FIGURE 3. MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MENOPAUSE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MENOPAUSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MENOPAUSE MARKET DYNAMICS
FIGURE 7. MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 10. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2030 (%)
FIGURE 14. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings